Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma Article Swipe
Related Concepts
Lymphoma
Antibiotics
Medicine
Disease
Cancer research
Immunology
Pharmacology
Internal medicine
Biology
Microbiology
Lise M. Lindahl
,
Andreas Willerslev-Olsen
,
Lise Mette Rahbek Gjerdrum
,
Pia Rude Nielsen
,
Edda Blümel
,
Anne Hald Rittig
,
Pamela Celis
,
Bjorn L. Herpers
,
Jürgen C. Becker
,
Birgitte Stausbøl‐Grøn
,
Mariusz A. Wasik
,
Maria Gluud
,
Simon Fredholm
,
Terkild B. Buus
,
Claus Johansen
,
Claudia Nastasi
,
Lukas Peiffer
,
Linda Kubat
,
Michael Bzorek
,
Jens Ole Eriksen
,
Thorbjørn Krejsgaard
,
Charlotte M. Bonefeld
,
Carsten Geisler
,
Tomas Mustelin
,
Erik Langhoff
,
Michael Givskov
,
Anders Woetmann
,
Mogens Kilian
,
Thomas Litman
,
Lars Iversen
,
Niels Ødum
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1182/blood.2018888107
· OA: W2962823845
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1182/blood.2018888107
· OA: W2962823845
This paper reports that aggressive antibiotic treatment inhibits disease activity and lymphocyte proliferation in cutaneous T-cell lymphoma (CTCL). The study offers important evidence for a link between bacterial infection, activation of the immune system, and CTCL progression.
Related Topics
Finding more related topics…